Mega-Merger Spinoff: Triangle Pharmaceuticals
Executive Summary
With the downsizing following mergers, some new companies are being formed by transplanted teams of executives. A team of ex-Wellcome executives have started an HIV-focused company pursuing a business Glaxo Wellcome probably couldn’t tackle. Is this the new shape of pharmaceutical start-ups?